Target intelligence / Profile preview

RNA, U6 small nuclear 1204, pseudogene (RNU6-1204P)

Target
RNU6-1204P
Molecular classification
Other
01

Overview

RNU6-1204P (RNA, U6 small nuclear 1204, pseudogene) is a processed pseudogene derived from the U6 small nuclear RNA (snRNA) gene, part of a large family of non-coding snRNA genes in the human genome[4][5][6]. U6 snRNA is a component of the spliceosome, crucial for pre-mRNA splicing and post-transcriptional modification[1][3]. However, RNU6-1204P itself does not encode a functional RNA or protein and is a nonfunctional genomic remnant arising from retrotransposition events mediated by LINE-1 elements[6]. Such pseudogenes are signatures of genome evolution and do not participate in biological processes, therapeutic mechanisms, or disease pathways. U6 snRNA pseudogenes are highly prevalent in vertebrate genomes and serve as markers for retrotransposition dynamics, especially those mediated by LINE-1 elements[6]. The parental U6 snRNA plays a crucial role in the catalytic activity of the spliceosome for intron removal, but its pseudogene copies, including RNU6-1204P, do not retain this function[1][3][6]. Expression data show presence in various tissues (e.g., dorsolateral prefrontal cortex, monocyte, colon), but this reflects transcriptional noise or genomic context rather than functional output[5]. No evidence exists to support this pseudogene as a receptor, enzyme, transcription factor, or transporter. This entry should primarily be used to annotate genomic structural variants or retrotransposition studies, not for therapeutic targeting or biomarker applications.

Other names
RNU6-1204PRNA, U6 small nuclear 1204, pseudogene
02

Biological functions

Other
03

Disease associations

Other

Beyond the preview

Go deeper on RNA, U6 small nuclear 1204, pseudogene (RNU6-1204P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 1204, pseudogene (RNU6-1204P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call